Stockreport

TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision's Allogeneic CD19 CAR T Cell Therapy Program for the Tr...

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF announced that it has entered into an agreement with Precision BioSciences , Inc. ( NASDAQ GS: DTIL) to acquire a worldwide license to Precision's Azercabtagene Zapreleu [Read more]